Technical Validation of a Tm Biosciences Luminex-Based Multiplex Assay for Detecting the American College of Medical Genetics Recommended Cystic Fibrosis Mutation Panel
- 31 July 2006
- journal article
- research article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 8 (3) , 371-375
- https://doi.org/10.2353/jmoldx.2006.050115
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Technical validation of a multiplex platform to detect thirty mutations in eight genetic diseases prevalent in individuals of Ashkenazi Jewish descentGenetics in Medicine, 2005
- Mutation detection, interpretation, and applications in the clinical laboratory settingMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005
- Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panelGenetics in Medicine, 2004
- Molecular screening for diseases frequent in Ashkenazi Jews: Lessons learned from more than 100,000 tests performed in a commercial laboratoryGenetics in Medicine, 2004
- Direct Visualization of Cystic Fibrosis Transmembrane Regulator Mutations in the Clinical Laboratory SettingClinical Chemistry, 2004
- Cystic fibrosis carrier screening: Issues in implementationGenetics in Medicine, 2002
- The I148T CFTR allele occurs on multiple haplotypes: A complex allele is associated with cystic fibrosisGenetics in Medicine, 2002
- Cystic fibrosis screening using the College panel: Platform comparison and lessons learned from the first 20,000 samplesGenetics in Medicine, 2002
- Updated assessment of cystic fibrosis mutation frequencies in non-Hispanic CaucasiansGenetics in Medicine, 2002
- Laboratory standards and guidelines for population-based cystic fibrosis carrier screeningGenetics in Medicine, 2001